NCT05598268 2022-10-28
A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.
ImmVira Pharma Co. Ltd
Phase 1/2 Unknown
ImmVira Pharma Co. Ltd
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Shenzhen BinDeBio Ltd.
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine